Of particular physiological interest, ascorbate, the ionized form of ascorb
ic acid, possesses strong reducing properties. However, it has been shown t
o induce oxidative stress and lead to apoptosis under certain experimental
conditions. Ascorbate in the brain is released during hypoxia, including st
roke, and is subsequently oxidized in plasma. The oxidized product (dehydro
ascorbate) is transported into neurons via a glucose transporter (GLUT) dur
ing a reperfusion period. The dehydroascorbate taken up by cells is reduced
to ascorbate by both enzymatic and non-enzymatic processes, and the ascorb
ate is stored in cells. This reduction process causes an oxidative stress,
due to coupling of redox reactions, which can induce cellular damage and tr
igger apoptosis. Ascorbate treatment decreased cellular glutathione (GSH) c
ontent, and increased the rates of lipid peroxide production in rat cortica
l slices. Wortmannin. a specific inhibitor of phosphatidylinositol (PI)-3-k
inase (a key enzyme in GLUT translocation). prevented the ascorbate induced
-decrease of GSH content, and suppressed ascorbate-induced lipid peroxide p
roduction. However. wortmannin was ineffective in reducing hydrogen peroxid
e (H2O2)-induced oxidative stress. The oxidative stress caused ceramide acc
umulation. which was proportionally changed with lipid peroxides when the c
ortical slices were treated with ascorbate. These differential effects supp
ort the hypothesis that GLUT efficiently transports the dehydroascorbate in
to neurons, causing oxidative stress. Crown Copyright (C) 2001 Published by
Elsevier Science B.V. All rights reserved.